248 related articles for article (PubMed ID: 10844009)
1. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists.
Kim DS; Szczypka MS; Palmiter RD
J Neurosci; 2000 Jun; 20(12):4405-13. PubMed ID: 10844009
[TBL] [Abstract][Full Text] [Related]
2. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
Collins SL; D'Addario C; Izenwasser S
Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
[TBL] [Abstract][Full Text] [Related]
3. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y
Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490
[TBL] [Abstract][Full Text] [Related]
4. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum.
Kim DS; Froelick GJ; Palmiter RD
J Neurosci; 2002 Nov; 22(22):9841-9. PubMed ID: 12427840
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
[TBL] [Abstract][Full Text] [Related]
7. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Hashitani T; Mizukawa K; Kumazaki M; Nishino H
Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
[TBL] [Abstract][Full Text] [Related]
8. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.
Yarkov AV; Hanger D; Reploge M; Joyce JN
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):551-62. PubMed ID: 14643855
[TBL] [Abstract][Full Text] [Related]
10. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
11. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
Asin KE; Bednarz L; Nikkel A; Perner R
J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
[TBL] [Abstract][Full Text] [Related]
12. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
Donovan DM; Miner LL; Perry MP; Revay RS; Sharpe LG; Przedborski S; Kostic V; Philpot RM; Kirstein CL; Rothman RB; Schindler CW; Uhl GR
Brain Res Mol Brain Res; 1999 Nov; 73(1-2):37-49. PubMed ID: 10581396
[TBL] [Abstract][Full Text] [Related]
13. PICK1-Deficient Mice Exhibit Impaired Response to Cocaine and Dysregulated Dopamine Homeostasis.
Jensen KL; Sørensen G; Dencker D; Owens WA; Rahbek-Clemmensen T; Brett Lever M; Runegaard AH; Riis Christensen N; Weikop P; Wörtwein G; Fink-Jensen A; Madsen KL; Daws L; Gether U; Rickhag M
eNeuro; 2018; 5(3):. PubMed ID: 29911172
[TBL] [Abstract][Full Text] [Related]
14. Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.
Chartoff EH; Marck BT; Matsumoto AM; Dorsa DM; Palmiter RD
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10451-6. PubMed ID: 11517332
[TBL] [Abstract][Full Text] [Related]
15. Alterations in behavioral responses to dopamine agonists in olfactory bulbectomized mice: relationship to changes in the striatal dopaminergic system.
Takahashi K; Nakagawasai O; Nemoto W; Nakajima T; Arai Y; Hisamitsu T; Tan-No K
Psychopharmacology (Berl); 2016 Apr; 233(7):1311-22. PubMed ID: 26856855
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior.
Richter A; Ebert U; Nobrega JN; Vallbacka JJ; Fedrowitz M; Löscher W
Neuroscience; 1999 Mar; 89(2):461-71. PubMed ID: 10077328
[TBL] [Abstract][Full Text] [Related]
17. A new knock-in mouse model of l-DOPA-responsive dystonia.
Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
[TBL] [Abstract][Full Text] [Related]
18. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity.
Kuhlmann AC; Guilarte TR
Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.
Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
Brain Res; 1999 Jun; 830(2):237-45. PubMed ID: 10366680
[TBL] [Abstract][Full Text] [Related]
20. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.
Guttman M; Stewart D; Hussey D; Wilson A; Houle S; Kish S
Neurology; 2001 Jun; 56(11):1559-64. PubMed ID: 11402115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
